Skip to content

The effects of desflurane and TIVA on regional cerebral oxygen saturation and postoperative delirium in gynecological laparoscopic surgery under Trendelenburg position

The effects of desflurane and TIVA on regional cerebral oxygen saturation and postoperative delirium in gynecological laparoscopic surgery under Trendelenburg position

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400084199
Enrollment
Unknown
Registered
2024-05-11
Start date
2024-05-15
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients undergoing elective Trendelenburg position gynecological laparoscopic surgery

Interventions

Group D:Continuously administer 5 Vol% desflurane inhalation for maintenance, and downregulate the plasma target concentration of propofol to 1.0 µ Continuous pumping in g/ml
Group T:Set the plasma target concentration of propofol to 2.0 µ Pump in g/ml

Sponsors

Women 's Hospital of Nanjing Medical University, Nanjing Women and Children’s Healthcare Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
45 Years to 65 Years

Inclusion criteria

Inclusion criteria: Patients undergoing gynecological laparoscopic surgery in the Trendelenburg position, with an American Society of Anesthesiologists (ASA) I-II rating, aged 45-65 years, 1 hour = surgery time = 3 hours.

Exclusion criteria

Exclusion criteria: 1. Severe cognitive impairment before surgery; 2. Epilepsy, hemiplegia, aphasia, and other cerebrovascular diseases; 3. Severe infection, dehydration, electrolyte disorders, and shock; 4. Severe cardiopulmonary (NYHA grade = 3, COPD), liver and kidney dysfunction (Child · Pugh grades B and C, creatinine>200umol/L); 5. Hemoglobin concentration<10mgdl-1; 6. Pregnancy status; 7. History of allergy to anesthetic drugs; 8. Have participated in other clinical trials within the first three months of enrollment and are currently participating in other clinical trials; 9. According to the judgment of the physician in charge of the trial, the implementation of the trial may increase the risk of the subjects, or patients may not be able to obtain sufficient trial data.

Design outcomes

Primary

MeasureTime frame
regional cerebral oxygen saturation;MMSE;MoCA;

Secondary

MeasureTime frame
Blood presure;PaO2;PaCO2;

Countries

China

Contacts

Public ContactZhang Huiying

Women 's Hospital of Nanjing Medical University, Nanjing Women and Children’s Healthcare Hospital

279763402@qq.com+86 138 5169 0367

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026